UK Regulator Flags Competition Concerns in McCormick-Unilever Food Deal, Sets Nov 18 Remedies Deadline
MKC is trading near its 52-week low of $43.25 (7.1% above the low).
Summary
The CMA's Phase 1 review found the McCormick purchase of most of Unilever's food business could substantially lessen competition in dry ingredient mixes and, separately, dry sauces sold to UK retailers. The regulator says the combined company would be by far the largest branded supplier in those categories, and that limited supermarket shelf space makes new entry or expansion hard. McCormick and Unilever have until November 18, 2026, to offer remedies; without them the CMA refers the deal to an in-depth Phase 2 investigation. That is a short window and the main near-term risk to closing. MKC was indicated at $46.38, down 0.73%, pre-market. This follows the CMA's September launch of the investigation and comes as McCormick is already absorbing $141.5M in special charges tied to the deal.
At the time of this announcement, MKC was trading at $46.33 on NYSE in the Manufacturing sector, with a market capitalization of approximately $12.6B. The 52-week trading range was $43.25 to $72.41. This news item was assessed with negative market sentiment and an importance score of 7 out of 10. Source: dpa-AFX.